These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
98 related articles for article (PubMed ID: 3415285)
1. Efficacy of systemic phenytoin in the treatment of junctional epidermolysis bullosa. Fine JD; Johnson L Arch Dermatol; 1988 Sep; 124(9):1402-6. PubMed ID: 3415285 [TBL] [Abstract][Full Text] [Related]
2. Lack of efficacy of phenytoin in recessive dystrophic epidermolysis bullosa. Epidermolysis Bullosa Study Group. Caldwell-Brown D; Stern RS; Lin AN; Carter DM N Engl J Med; 1992 Jul; 327(3):163-7. PubMed ID: 1608407 [TBL] [Abstract][Full Text] [Related]
4. [Phenytoin therapy in recessive dystrophic epidermolyses (epidermolysis bullosa dystrophica type Hallopeau-Siemens and epidermolysis bullosa dystrophica inversa)]. Wirth H; Nesch A; Ostapowicz B; Anton-Lamprecht I Z Hautkr; 1983 Apr; 58(8):555-74. PubMed ID: 6858283 [TBL] [Abstract][Full Text] [Related]
5. Therapeutic efficacy of phenytoin in recessive dystrophic epidermolysis. A comparison of short- and long-term treatment. Cooper TW; Bauer EA Arch Dermatol; 1984 Apr; 120(4):490-5. PubMed ID: 6703753 [TBL] [Abstract][Full Text] [Related]
10. Dental caries risk in hereditary epidermolysis bullosa. Wright JT; Fine JD; Johnson L Pediatr Dent; 1994; 16(6):427-32. PubMed ID: 7854950 [TBL] [Abstract][Full Text] [Related]
11. Eye involvement in inherited epidermolysis bullosa: experience of the National Epidermolysis Bullosa Registry. Fine JD; Johnson LB; Weiner M; Stein A; Cash S; Deleoz J; Devries DT; Suchindran C Am J Ophthalmol; 2004 Aug; 138(2):254-62. PubMed ID: 15289135 [TBL] [Abstract][Full Text] [Related]
13. Phenytoin therapy of recessive dystrophic epidermolysis bullosa. Clinical trial and proposed mechanism of action on collagenase. Bauer EA; Cooper TW; Tucker DR; Esterly NB N Engl J Med; 1980 Oct; 303(14):776-81. PubMed ID: 6251365 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of the efficacy of topical bufexamac in epidermolysis bullosa simplex. A double-blind placebo-controlled crossover trial. Fine JD; Johnson L Arch Dermatol; 1988 Nov; 124(11):1669-72. PubMed ID: 3178249 [TBL] [Abstract][Full Text] [Related]
17. The generalized atrophic benign form of junctional epidermolysis bullosa. Experience with four patients in the United States. Paller AS; Fine JD; Kaplan S; Pearson RW Arch Dermatol; 1986 Jun; 122(6):704-10. PubMed ID: 3521495 [TBL] [Abstract][Full Text] [Related]